MGIM
MYGN icon

M&G Investment Management’s Myriad Genetics MYGN Stock Holding History

M&G Investment Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-213,024
Closed -$6.82K – 655
2021
Q3 		$6.82K Buy
213,024
+250
+0.1% +$8.3K 0.02% 344
2021
Q2 		$6.6K Buy
+212,774
New +$6.15M 0.02% 350

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

M&G Investment Management's MYGN Position: Q4 2021 in Review

M&G Investment Management sold out of Myriad Genetics (MYGN) in Q4 2021, closing a stake of 213,024 shares — an estimated $6.82K sold.

M&G Investment Management first reported a position in MYGN in Q2 2021 and held it in 2 quarters. The position peaked at $6.82K in Q3 2021. 197 funds tracked by Wall St. Rank hold MYGN as of Q4 2021.

  • M&G Investment Management reported no remaining Myriad Genetics position as of Q4 2021 after selling out during the quarter.
  • M&G Investment Management sold 213,024 Myriad Genetics shares in Q4 2021, an estimated $6.82K.
  • M&G Investment Management first reported a position in Myriad Genetics in Q2 2021 and held it in 2 quarters.
  • M&G Investment Management's Myriad Genetics position peaked at $6.82K in Q3 2021.
  • 197 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2021.

Based on M&G Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.